Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-24 @ 1:00 PM
NCT ID:
NCT06769061
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or above
* Diagnosis of uterine (endometrial) cancer, ovarian cancer and cervical cancer
* ECOG=0-2
* Life expectancy of \> 6 months
* Completed at least 6 cycles of carboplatin or cisplatin chemotherapy together with paclitaxel at least 3 months before joining the study
* Able to read and understand the questionnaires
* PNQ score of C or above
Exclusion Criteria:
* Bleeding tendency
* Abnormal clotting profile
* Platelet lower than 50
* Received acupuncture in the past
* Currently receiving chemotherapy treatment
* Known neurological disorders or pre-existing neuropathy unrelated to chemotherapy
* Routinely take aspirin or any anticoagulant drugs
* Having active skin infection
* With pacemaker
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06769061
Study Brief:
Protocol Section:
NCT06769061